Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Axsome Therapeutics, Inc. (AXSM) had Non-Operating Income/Expense of $-1.12M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$170.99M |
|
$-47.23M |
|
$11.91M |
|
$159.08M |
|
$217.10M |
|
$-46.11M |
|
|
Non-Operating Income/Expense |
$-1.12M |
$-47.23M |
|
$-47.23M |
|
$-47.23M |
|
$-47.23M |
|
$-47.23M |
|
$-47.23M |
|
$-46.11M |
|
$-43.54M |
|
50.02M |
|
50.02M |
|
$-0.94 |
|
$-0.94 |
|
| Balance Sheet Financials | |
$565.34M |
|
$0.60M |
|
$103.91M |
|
$669.25M |
|
$360.29M |
|
$122.32M |
|
$235.23M |
|
$595.52M |
|
$73.73M |
|
$19.56M |
|
$73.73M |
|
50.31M |
|
| Cash Flow Statement Financials | |
$-74.75M |
|
$-0.41M |
|
$85.08M |
|
$315.35M |
|
$325.27M |
|
$9.92M |
|
$71.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
0.62 |
|
2.61 |
|
93.03% |
|
-26.97% |
|
-26.97% |
|
-- |
|
-27.62% |
|
-27.62% |
|
$-75.16M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.50 |
|
0.87 |
|
103.43 |
|
-64.06% |
|
-241.47% |
|
-7.06% |
|
-24.09% |
|
$1.47 |
|
$-1.50 |
|
$-1.49 |
|